Ledger.Open graph →
SEC Form D · filed July 20, 2018

AiVita Biomedical, Inc

Offering
$17.0M
Sold
$17.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
IRVINE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

David Roblin · Abingdon, United KingdomExecCamac Capital, LLC · New York, NYExecan Arizona limited liability company Quyp Development Services LLC · Phoenix, AZExec · DirectorPeter T. Clark · London, United KingdomDirectorCamac Partners, LLC · New York, NYDirectorFabian Alt · Houston, TXExec · DirectorEckhard Alt, M.D., Ph.D · Houston, TXDirectorKlaus Keller · Houston, TXExecJohn L. Youngblood · New York, NYDirectorSandra L. Wijnberg · New York, NYExecUngbae B. Lee · Irvine, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗